$(CLOV)$ We are sitting@2.36 B valuation and "Clover continues to scale with a current annual revenue run rate of $1.7 billion. We expect our strong growth to continue," so the current valuation is 1.38x of revenue so its definitely undervalued but current problem is its expanding and its expenses are way higher so if they reduce their expenses and continue with their revenue growth which should be possible by 2nd qtr of 2022 the stock would go parabolic any thoughts